Association of Circulating Transforming Growth Factor beta, Tumor Necrosis Factor alpha and Basic Fibroblast Growth Factor with Restenosis after Transluminal Angioplasty

European Journal of Vascular and Endovascular Surgery

Volumn 34, Issue 1, 2007, Pages 35-43

  Wildgruber, M ^a   Weiss, W ^a   Berger, H ^a   Wolf, O ^a   Eckstein, H H ^a   Heider, P ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angioplasty; Growth factors; Peripheral arterial occlusive disease; Restenosis; Transforming Growth Factor beta

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT;

ADULT; AGED; ANGIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE THROMBOSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RESTENOSIS; RETREATMENT; STENT;

AGED; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249775477     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2007.02.009     Document Type: Article

References (33)

1. Wyttenbach R., Gallino A., Alerci M., Mahler F., Cozzi L., Di Valentino M., et al. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation 110 (2004) 1156-1161
2. Cheng S.W., Ting A.C., and Wong J. Endovascular stenting of superficial femoral artery stenosis and occlusions: results and risk factor analysis. Cardiovasc Surg 9 (2001) 133-140
3. Schwartz R.S., Topol E.J., Serruys P.W., Sangiorgi G., and Holmes Jr. D.R. Artery size, neointima, and remodeling: time for some standards. J Am Coll Cardiol 32 (1998) 2087-2094
4. Ryan S.T., Koteliansky V.E., Gotwals P.J., and Lindner V. Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J Vasc Res 40 (2003) 37-46
5. Sinha S., Heagerty A.M., Shuttleworth C.A., and Kielty C.M. Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury. Cardiovasc Res 53 (2002) 971-983
6. Tanaka H., Sukhova G., Schwartz D., and Libby P. Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor. Arterioscler Thromb Vasc Biol 16 (1996) 12-18
7. Potkin B.N., Keren G., Mintz G.S., Douek P.C., Pichard A.D., Satler L.F., et al. Arterial responses to balloon coronary angioplasty: an intravascular ultrasound study. J Am Coll Cardiol 20 (1992) 942-951
8. Sangiorgi G., Taylor A.J., Farb A., Carter A.J., Edwards W.D., Holmes D.R., et al. Histopathology of postpercutaneous transluminal coronary angioplasty remodeling in human coronary arteries. Am Heart J 138 (1999) 681-687
9. Jovinge S., Hultgardh-Nilsson A., Regnstrom J., and Nilsson J. Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 17 (1997) 490-497
10. Misiakos E.P., Kouraklis G., Agapitos E., Perrea D., Karatzas G., Boudoulas H., et al. Expression of PDGF-A, TGFb and VCAM-1 during the developmental stages of experimental atherosclerosis. Eur Surg Res 33 (2001) 264-269
11. Neschis D.G., Safford S.D., Hanna A.K., Fox J.C., and Golden M.A. Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model. J Vasc Surg 27 (1998) 126-134
12. Niemann-Jonsson A., Ares M.P., Yan Z.Q., Bu D.X., Fredrikson G.N., Branen L., et al. Increased rate of apoptosis in intimal arterial smooth muscle cells through endogenous activation of TNF receptors. Arterioscler Thromb Vasc Biol 21 (2001) 1909-1914
13. Otsuka G., Agah R., Frutkin A.D., Wight T.N., and Dichek D.A. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways. Arterioscler Thromb Vasc Biol 26 (2006) 737-743
14. Shi Y., O'Brien Jr. J.E., Fard A., and Zalewski A. Transforming growth factor-beta 1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol 16 (1996) 1298-1305
15. Majesky M.W., Lindner V., Twardzik D.R., Schwartz S.M., and Reidy M.A. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest 88 (1991) 904-910
16. Warner S.J., and Libby P. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J Immunol 142 (1989) 100-109
17. Lindner V., Lappi D.A., Baird A., Majack R.A., and Reidy M.A. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68 (1991) 106-113
18. Lindner V., and Reidy M.A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 88 (1991) 3739-3743
19. Stone G.W., and Aronow H.D. Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy. Mayo Clin Proc 81 (2006) 641-652
20. Strecker E.P., Boos I.B., Gottmann D., and Vetter S. Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1- and 2-year results. Eur Radiol 14 (2004) 302-308
21. Kropf J., Schurek J.O., Wollner A., and Gressner A.M. Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. Clin Chem 43 (1997) 1965-1974
22. Jager K.A., Phillips D.J., Martin R.L., Hanson C., Roederer G.O., Langlois Y.E., et al. Noninvasive mapping of lower limb arterial lesions. Ultrasound Med Biol 11 (1985) 515-521
23. Moneta G.L., Yeager R.A., Antonovic R., Hall L.D., Caster J.D., Cummings C.A., et al. Accuracy of lower extremity arterial duplex mapping. J Vasc Surg 15 (1992) 275-283
24. Neuerburg-Heusler D., and Karasch T. Determining the degree of stenosis of peripheral arteries. Hemodynamic and ultrasound principles. Vasa 25 (1996) 109-113
25. Nikol S., Isner J.M., Pickering J.G., Kearney M., Leclerc G., and Weir L. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest 90 (1992) 1582-1592
26. Geng Y.J., Wu Q., Muszynski M., Hansson G.K., and Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 16 (1996) 19-27
27. Danielsson P., Schatz P., Swartbol P., Truedsson L., Danielsson G., Zdanowski Z., et al. Response of inflammatory markers to balloon angioplasty in peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg 20 (2000) 550-555
28. Katinioti A.A., Tousoulis D., Economou E., Stefanadis C., Trikas A., Tentolouris C., et al. Basic fibroblast growth factor changes in response to coronary angioplasty in patients with stable angina. Int J Cardiol 84 (2002) 195-199
29. Tsakiris D.A., Tschopl M., Jager K., Haefeli W.E., Wolf F., and Marbet G.A. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 142 (1999) 193-200
30. Bohm I., Speck U., and Schild H. Cytokine profiles after nonionic dimeric contrast medium injection. Invest Radiol 38 (2003) 776-783
31. Ward M.R., Agrotis A., Kanellakis P., Hall J., Jennings G., and Bobik A. Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting. Arterioscler Thromb Vasc Biol 22 (2002) 940-948
32. Roller R.E., Obernosterer A., Dorr A., and Schnedl W.J. No association of TGF-beta1 antigen with the development of restenosis in patients undergoing peripheral angioplasty. Thromb Haemost 84 (2000) 518-519
33. Rider C.C. Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily. Biochem Soc Trans 34 (2006) 458-460